🔎 Trials Near Me

Acasă › Neuroblastom › Missouri

Studii clinice pentru Neuroblastom în Missouri

10 studii pentru Neuroblastom caută participanți în Missouri.

Orașe în Missouri

Text oficial al studiului (în engleză)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • University of Missouri Children's Hospital, Columbia
  • Children's Mercy Hospitals and Clinics, Kansas City
  • Washington University School of Medicine, St Louis
  • și încă 1
În curs de recrutareFaza 3
Până la vârsta de 30 · Toate sexele · Actualizat 2 oct. 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Children's Mercy Hospital ( Site 1024), Kansas City
În curs de recrutareFaza 1/2
6 Months – 25 Years · Toate sexele · Actualizat 17 sept. 2026 · NCT06395103

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Cardinal Glennon Children's Medical Center, St Louis
În curs de recrutareFaza 2
Până la vârsta de 22 · Toate sexele · Actualizat 4 sept. 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Cardinal Glennon Children's Medical Center, St Louis
În curs de recrutareFaza 1/2
Până la vârsta de 26 · Toate sexele · Actualizat 3 sept. 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Children's Mercy Hospitals and Clinics, Kansas City
  • Cardinal Glennon Children's Medical Center, St Louis
În curs de recrutareFaza 1/2
Până la vârsta de 30 · Toate sexele · Actualizat 3 sept. 2026 · NCT06541262

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

  • Cardinal Glennon Children's Medical Center, St Louis
În curs de recrutareFaza 2
Vârste de la 1 la 21 · Toate sexele · Actualizat 3 sept. 2026 · NCT06540963

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • University of Missouri Children's Hospital, Columbia
  • Children's Mercy Hospitals and Clinics, Kansas City
  • Washington University School of Medicine, St Louis
  • și încă 1
În curs de recrutareFaza 3
365 Days – 30 Years · Toate sexele · Actualizat 25 aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Washington University School of Medicine, St Louis
În curs de recrutareFaza 1/2
12 Months – 30 Years · Toate sexele · Actualizat 25 aug. 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Cardinal Glennon Children's Hospital, St Louis
În curs de recrutareFaza 2
12 Months – 21 Years · Toate sexele · Actualizat 12 aug. 2026 · NCT05489887

SPEARHEAD-3 Pediatric Study

  • Washington University, St Louis
În curs de recrutareFaza 1/2
Vârste de la 2 la 21 · Toate sexele · Actualizat 11 aug. 2026 · NCT05642455

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.